Ironwood Pharmaceuticals (IRWD) is undergoing a challenging transition with LINZESS but has promising growth potential with ...

The company's strategic reorganization aims to streamline its operations and reduce costs, particularly those associated with its flagship product, LINZESS. Despite the expected growth in LINZESS ...

Medicare Part D prescription drug plans and Medicare Advantage plans that include prescription drug coverage typically cover the cost of Linzess. However, as private insurers provide Medicare Part ...